• About
  • Team
  • Contact
  • Editorial Standards
  • Core Values
  • Terms of Service
  • Privacy Policy
  • Affiliate Disclosure
Resist the Mainstream
No Result
View All Result
STORE
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
NEWSLETTER
Get Ad-Free Login Manage Account
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
No Result
View All Result
Resist the Mainstream
No Result
View All Result

Regulator Reviewing Reports of ‘Rare’ and Serious Condition Linked to Moderna Vaccine

RTM Staff by RTM Staff
November 11, 2021
2

RELATED

TikTok Star Jehane Thomas Dies Suddenly at Age 30

Watch: Fauci Tears Up While Watching the Biden Inauguration in New Documentary: Held Back ‘Despair’

Europe’s drug regulator on Thursday confirmed it is investigating reports of a blood condition in recipients of Moderna’s mRNA COVID-19 vaccine.

According to a bulletin posted by the European Medicines Agency (EMA), it is reviewing six cases capillary leak syndrome, considered a “very rare disorder,” after they were reported in the EMA’s EudraVigilance database.

Advertisements

“At this stage, it is not yet clear whether there is a causal association between vaccination and the reports of capillary leak syndrome,” the EMA wrote on Thursday, adding that “these reports point to a safety signal … information on new, or changes in, adverse events that may potentially be associated with a medicine or vaccine and that warrant further investigation.”

The review also will address the risk of capillary leak syndrome in groups who have a medical history of the disorder.

As a result, EMA researchers will “evaluate all the available data to decide if a causal relationship is considered likely or not,” the bulletin reads.

It also noted there is “currently insufficient evidence” of a link between Moderna’s vaccine and cases of multisystem inflammatory syndrome.

Capillary leak syndrome, according to the Mayo Clinic, is a rare disorder involving repeated leaks of large amounts of plasma from blood vessels into nearby body cavities and muscles. The condition—known as Clarkson’s disease—can result in a sharp drop in blood pressure that can lead to organ failure or even death.

Advertisements

“Attacks may be triggered by an upper respiratory infection or intense physical exertion. The frequency of attacks can range from several a year to a single instance in a lifetime,” says the clinic.

Symptoms include nausea, fatigue, irritability, muscle aches, more thirst, or a sudden increase in body weight, the clinic’s website says.

Earlier in the year, the EMA’s safety committee concluded that capillary leak syndrome should be added to the product information as a side effect of AstraZeneca’s vaccine, which uses different technology than Moderna’s.

Outside of the European Union, Canada’s health agency earlier this year updated the label for the Oxford-AstraZeneca and Covishield COVID-19 vaccines to add capillary leak syndrome as a possible side-effect. The Canadian agency included a warning for individuals with a history of the ailment to not receive those vaccines.

This is an excerpt from The Epoch Times.

Scroll down to leave a comment and share your thoughts.

TRENDING TODAY

‘Game-Changer’ Costello Testimony May Have Sunk Manhattan DA’s Case Against Trump, Dershowitz Says
Politics

‘Game-Changer’ Costello Testimony May Have Sunk Manhattan DA’s Case Against Trump, Dershowitz Says

by Gary Ray
March 22, 2023
Utah Gets Official New Flag After Governor Cox Signs Bill, Executive Order
US

Utah Gets Official New Flag After Governor Cox Signs Bill, Executive Order

by RTM Staff
March 22, 2023


© 2023 Resist the Mainstream

Get Ad-Free Login Manage Account
No Result
View All Result
  • Newsletter
  • Store
  • Politics
  • US
  • Media Watch
  • World
  • COVID
  • Story of Hope
  • Opinion
    • Cartoons
  • About
  • Team
  • Contact
  • Editorial Standards
  • Core Values
  • Terms of Service
  • Privacy Policy
  • Affiliate Disclosure

© 2023 Resist the Mainstream